###begin article-title 0
###xml 61 66 <span type="species:ncbi:9606">human</span>
Pro370Leu mutant myocilin impairs mitochondrial functions in human trabecular meshwork cells
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
Oxidative stress is a risk factor for the onset and progression of primary open-angle glaucoma (POAG), but the exact molecular basis remains unknown. Here, we investigated the mechanisms for Pro370Leu mutant myocilin to induce mitochondrial dysfunction and subsequent reactive oxygen species (ROS) generation in trabecular meshwork (TM) cells obtained from POAG individuals.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 329 331 329 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 364 366 364 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 367 368 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 391 393 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 451 452 451 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 21 26 <span type="species:ncbi:9606">human</span>
Primary non-diseased human TM cultures were transfected with pIRES-EGFP (Mock), pIRES-wild-type (WT), or pIRES-Pro370Leu mutant myocilin. Transfection efficiency and myocilin subcellular localization were determined by polymerase chain reaction (PCR), western blot analysis, and confocal microscopy. ROS levels as well as free Ca2+ concentrations in cytoplasm ([Ca2+]c) and mitochondria ([Ca2+]m) were examined by 2'7'-dichlorofluorescein diacetate (H2-DCF-DA), Fluo-3 acetoxymethyl ester (Fluo-3/AM), and Rhod-2 acetoxymethyl ester (rhod-2/AM), respectively, using flow cytometry. Mitochondrial functions were revealed by changes in mitochondrial membrane potential (DeltaPsim) and ATP production, which were found by fluorescent probe 5,5',6,6'-tetrachloro-1,1'3,3'-tetraethylbenzimid azolocarbocyanine iodide (JC-1) and a luciferin/luciferase-based ATP assay, respectively.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 361 363 355 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 364 365 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 374 376 368 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 377 378 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
Both WT and Pro370Leu mutant myocilin are localized in the mitochondria of TM cells as indicated using confocal microscopy and western blot analysis. Overexpression of WT myocilin decreases DeltaPsim, which is further reduced by Pro370Leu mutant myocilin. TM cells that overexpressed Pro370Leu mutant myocilin have greater cell death, higher endogenous ROS, [Ca2+]c, and [Ca2+]m levels, and lower ATP production, and yet, these effects are not seen in the overexpression of WT myocilin.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
Our findings suggested that Pro370Leu mutant myocilin causes mitochondrial defects, which may lead to TM cell dysfunction and even cell death. Therefore, preventive measures targeting mitochondrial protection may delay the onset of glaucoma in individuals carrying the Pro370Leu myocilin mutation.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 113 119 <span type="species:ncbi:9606">people</span>
Glaucoma is the second leading cause of irreversible blindness worldwide, which affects approximately 70 million people [1]. Primary open-angle glaucoma (POAG), the most common form of this disease, contributes to a large proportion of blindness cases in the elderly [2-6].
###end p 11
###begin p 12
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
POAG is associated with intraocular pressure (IOP) elevation, which is caused by abnormal resistance of aqueous outflow through the trabecular meshwork (TM), a specialized tissue lining the outflow pathway of the eye [7,8]. The mechanisms that lead to such abnormalities in TM are largely unknown. Possible means include gene mutations (e.g., myocilin, optineurin) [9,10], vascular alterations [11,12], mechanical injuries [13-16], and local oxidative stress [17,18]. Elevated IOP leads to progressive optic neuropathy and ganglion cell death in the neural retina that often result in irreversible loss of vision [13-16].
###end p 12
###begin p 13
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 598 606 <span type="species:ncbi:9606">patients</span>
Myocilin is also known as "TIGR" for trabecular meshwork-inducible glucocorticoid response. Mutation of this gene was first reported to associate with juvenile-onset open-angle glaucoma (JOAG) in 1997 [19]. Later, more than 70 mutation sites in the myocilin gene were identified to be related to the pathogenesis of approximately 3% of familial autosomal dominant adult-onset open-angle glaucoma and a greater proportion of JOAG [20]. Among the identified mutations, the Pro370Leu mutation (OMIM ; allelic variant 0.007) is responsible for one of the most severe glaucoma phenotypes [21-24]. These patients have high IOP, typical glaucomatous cupping of the optic disc, and a thinner nerve fiber layer and are unresponsive to standard pharmacological treatments [25]. In this study, we investigated how Pro370Leu mutant myocilin affects the TM cells.
###end p 13
###begin p 14
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
Myocilin is a signal peptide secretary protein [26-29]. It has both intracellular and intercellular functions [30,31] and can be found in various organelles such as the endoplasmic reticulum (ER), Golgi apparatus [32-38], and mitochondria [39-42]. Myocilin is imported into the mitochondria and the specific transporter is currently unknown [42]. It localizes on inner and outer membranes as well as in the intermembranous space but not in the mitochondrial matrix [42]. Although the myocilin transcript and protein are ubiquitously expressed in multiple ocular tissues [43], its interaction with the mitochondria appears to be cell specific. Myocilin-mitochondria interaction is seen in TM cells and astrocytes but not in corneal Ô¨Åbroblasts [40,41]. These findings prompt us to hypothesize that myocilin mutations may alter mitochondrial function in TM cells, which explains the specificity of myocilin mutations to glaucoma.
###end p 14
###begin p 15
Here, we report that TM cells that overexpress Pro370Leu mutant myocilin demonstrate features of mitochondrial dysfunction including increased cellular reactive oxygen species (ROS) and decreased mitochondrial membrane potential (DeltaPsim) and ATP production as well as dysfunction in calcium regulation. These findings indicate Pro370Leu mutant myocilin may increase vulnerability of TM cells to various cellular insults and cause impaired functioning.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Materials
###end title 17
###begin p 18
###xml 208 209 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 488 494 <span type="species:ncbi:9986">rabbit</span>
###xml 500 505 <span type="species:ncbi:9606">human</span>
###xml 546 550 <span type="species:ncbi:9925">goat</span>
###xml 556 561 <span type="species:ncbi:9606">human</span>
All tissue culture reagents were obtained from Gibco BRL (Gaithersburg, MD). The luciferin/luciferase-based ATP assay kit was purchased from Sigma (St. Louis, MO). 2',7'-dichlorodihydrofluorescin diacetate (H2-DCF-DA), 5,5',6,6'-tetrachloro-1,1'3,3'-tetraethylbenzimid azolocarbocyanine iodide (JC-1), Hoechst33342, MitoTracker Red, Fluo-3 acetoxymethyl ester (Fluo-3/AM) and Rhod-2 acetoxymethyl ester (Rhod-2/AM; the dyes) were obtained from Molecular Probes (Carlsbad, CA). Polyclonal rabbit anti-human myocilin (N-15) antibody and polyclonal goat anti-human COX IV antibody were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
###end p 18
###begin title 19
Plasmid construction
###end title 19
###begin p 20
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
The full-length myocilin cDNA clone has been described in our previous article and in another study [44,45]. Briefly, EcoRI and BamHI restriction enzyme cleavage sites were added to the 5' and 3' end of the myocilin cDNA by polymerase chain reaction (PCR). The obtained fragment was cloned into mammalian expression plasmid (pIRES and pIRES-EGFP; Clontech, Palo Alto, CA). We generated Pro370Leu mutations with the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. The specific PCR primers for Pro370Leu mutagenesis were as follows: 5'-CTA CCA CGG ACA GTT CCT GTA TTC TTG GGG TGG CTA-3' and 5'-TAG CCA CCC CAA GAA TAC AGG AAC TGT CCG TGG TAG-3'. The sequence of the Pro370Leu myocilin mutant plasmid was verified using DNA sequencer to confirm correct insertion and the absence of undesirable mutations.
###end p 20
###begin title 21
Tissue procurement and cell culture
###end title 21
###begin p 22
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 389 394 <span type="species:ncbi:9606">human</span>
Procurement of the human tissue was performed according to the tenets of the Declaration of Helsinki. Normal human eyes were obtained from the Zhongshan Ophthalmic Center Eye Bank in Guangzhou, China as we mentioned in our previous studies [18,46]. The procurement of tissue was approved by the IRB Committee at the Sun Yat-sen University at Guangzhou. Normal TM cells were derived from 5 human donor eyes with no known ocular diseases. These eyes were obtained within 24 h after death and were dedicated for corneal transplantation. The ages of the donors ranged from 20 to 40 years.
###end p 22
###begin p 23
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r49">49</xref>
###xml 669 670 668 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 353 359 <span type="species:ncbi:9913">bovine</span>
The TM cultures were prepared as described before [18,46-49]. Briefly, human TM was carefully dissected from the anterior segments and the whole corneal layer of the donor eyes. The explants were placed in 24 well culture plates (Corning Costar, Cambridge, MA) containing Dulbecco's modified Eagle's medium (DMEM), which was supplemented with 15% fetal bovine serum, 2 mM L-glutamine, penicillin (100 U/ml), and streptomycin (100 mug/ml). Cells gradually migrated from the TM explants and formed a confluent monolayer in approximately 10-14 days. Fourth- or fifth-passage cells were used for all the studies described here. The TM cells were seeded at a density of 1x105 cells per well using six-well tissue culture plates, and micrographs of the cultures were taken three days post seeding at approximately 80% confluency.
###end p 23
###begin p 24
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 253 255 253 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;7</sup>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r50">50</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r51">51</xref>
The identity of the TM cells has been characterized in our previous publications using immunocytochemical staining of fibronectin, laminin, and neuron-specific enolase [18,46], and by the increased myocilin expression after exposure to dexamethasone (10-7 M) for three days [50,51].
###end p 24
###begin title 25
Gene transfection
###end title 25
###begin p 26
Fourth- or fifth-passage TM cells grown to about 80%-85% confluence were incubated for 6 h with 1 mug of pIRES-EGFP-WT, pIRES-WT, pIRES-EGFP-Pro370Leu, or pIRES-Pro370Leu myocilin expression plasmids in the presence of Lipofectamine (0.3% v/v; Invitrogen). The cells were then washed and cultured for another 24 h or 48 h. The efficiency of transfection was estimated by transiently transfecting the cells with pIRES-EGFP vector, and the percentage of EGFP-positive cells were analyzed using flow cytometry. The transfection efficiency was about 38%-46%. Also, TM cells transfected with the pIRES (Mock) plasmid was used as a negative control.
###end p 26
###begin title 27
Myocilin mRNA measurement
###end title 27
###begin p 28
###xml 467 475 461 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myocilin</italic>
###xml 522 527 516 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 589 597 583 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myocilin</italic>
###xml 698 703 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
Myocilin mRNA expression was analyzed by reverse transcriptase-polymerase chain reaction (RT-PCR). Total mRNA from TM samples with or without transfection were isolated using RNeasy reagents (Qiagen, Valencia, CA) according to the manufacturer's protocol. First-strand cDNA was synthesized using iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). RT-PCR was performed using iTaq polymerase (Bio-Rad) at an annealing temperature of 59 degreesC for 30 cycles for both myocilin and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers. The primer sequences used in PCR reactions for the myocilin gene are (sense) 5'-CTG GAA ACC CAA ACC AGA GA-3' and (antisense) 5'-AAA TTC GGG AAG CAG GAA CT-3'. GAPDH was used as the internal RNA loading control, and the samples where no reverse transcriptase (NRTs) was added to the PCR experiments were used as negative controls to confirm that the amplification was RNA dependent. PCR products were resolved by 1% agarose gel electrophoresis.
###end p 28
###begin title 29
Mitochondrial isolation and total cell lysate preparation
###end title 29
###begin p 30
###xml 308 309 308 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 457 463 <span type="species:ncbi:9913">bovine</span>
For mitochondrial protein extraction, mitochondria from TM cultures were isolated using a mitochondria isolation kit for cultured cells (Pierce Chemical Co., Rockford, IL). Briefly, after being transfected with pIRES-EGFP plasmid (Mock), pIRES-EGFP-WT myocilin, and pIRES-EGFP-Pro370Leu for 48 h, three 75 cm2 culture flasks of 85% confluent cells were homogenized in ice-cold buffer (225 mM mannitol, 75 mM sucrose, 1 mM EGTA, 5 mM HEPES, 2 mg/ml fat-free bovine serum albumin [BSA], and protease inhibitor cocktail [Roche Diagnostics, Branchburg, NJ]) with 30 up-and-down strokes using a motor-driven Teflon pestle that is tight-fitted to a Dounce homogenizer (Kontes Co., Vineland, NJ). The homogenate was centrifuged at 1,000x g for 10 min at 4 degreesC, and the resulting supernatant was layered onto 5 ml of 7.5% Ficoll medium (Sigma, St. Louis, MO) after being layered onto 5 ml of 10% Ficoll medium (0.3 M sucrose, 50 muM EGTA, and 10 mM HEPES) and centrifuged at 79,000x g for 30 min. Mitochondrial pellets were re-suspended in 500 mul of ice-cold mitochondrial buffer in a pre-weighed 0.5 ml tube and centrifuged. The supernatant was then discarded and the pellet weight estimated. The mitochondrial pellets were then lysed in 0.5 ml Cytobuster lysis buffer (Novagen, Madison, WI) and centrifuged, and protein concentrations were estimated using Dc Protein Assay Kit (Bio-Rad).
###end p 30
###begin p 31
For total cellular protein preparation, TM cells transfected with pIRES plasmid (Mock), pIRES-WT myocilin, or pIRES-Pro370Leu mutant myocilin for 48 h were lysed in 0.5 ml Cytobuster lysis buffer and centrifuged, and protein concentrations were estimated using DC Protein Assay Kit.
###end p 31
###begin title 32
Western blot analysis
###end title 32
###begin p 33
###xml 233 239 <span type="species:ncbi:9986">rabbit</span>
###xml 245 250 <span type="species:ncbi:9606">human</span>
###xml 299 303 <span type="species:ncbi:9925">goat</span>
###xml 309 314 <span type="species:ncbi:9606">human</span>
###xml 472 476 <span type="species:ncbi:9925">goat</span>
###xml 482 488 <span type="species:ncbi:9986">rabbit</span>
Forty micrograms of mitochondrial protein or total cellular protein was separated by SDS-PAGE and transferred onto nitrocellulose membranes (Bio-Rad). After blocking with 5% (w/v) dried milk, membranes were incubated with polyclonal rabbit anti-human myocilin (N-15) antibody (1:200) and polyclonal goat anti-human COX IV antibody (1:200; Santa Cruz Biotechnologies) at 4 degreesC overnight followed by washing and incubation with Horsheradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (1:200; Bio-Rad) for 1 h at room temperature. Bound antibody was determined using the Bio-Rad ECL detection system.
###end p 33
###begin title 34
Morphological analysis of trabecular meshwork cultures after transfection
###end title 34
###begin p 35
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
TM cells seeded at a density of 1x105 cells per well in six-well plates were transfected for 24 h with pIRES-EGFP plasmid (Mock), pIRES-EGFP-WT myocilin, or pIRES-EGFP-Pro370Leu mutant myocilin. Phase contrast micrographs were taken to examine morphological changes after transfection.
###end p 35
###begin p 36
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Some of the cells were seeded in a 35 mm2 Petri dish and transfected with pIRES-EGFP plasmid (Mock), pIRES-EGFP-WT myocilin, or pIRES-EGFP-Pro370Leu mutant myocilin for 8 h. Cells were either stained with 1 mug/ml Hoechst33342 to illustrate the nuclei or labeled with 50 nM of MitoTracker Red to show the mitochondria. The staining pattern was visualized by Zeiss 100M confocal microscope (Carl Zeiss Jena GmbH, Jena, Germany).
###end p 36
###begin title 37
Measurement of reactive oxygen species
###end title 37
###begin p 38
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r52">52</xref>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r53">53</xref>
###xml 265 266 265 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 304 305 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 355 356 348 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 455 456 448 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 457 458 450 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 493 494 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cellular oxidative stress was determined by cytoplasmic ROS levels [52,53]. Briefly, cells transfected with pIRES plasmid (Mock), pIRES-WT myocilin, or pIRES-Pro370Leu mutant myocilin and non-transfected cells were trypsinized and re-suspended in freshly prepared H2-DCF-DA (0.4 muM) at a density of 2x106 cells/ml at 37 degreesC in the dark for 30 min. H2-DCF-DA penetrates into cells and emits green fluorescence upon oxidation through a reaction with H2O2 and to a certain extent with NO. H2-DCF-DA-loaded cells were rinsed twice with PBS and analyzed immediately by flow cytometry at 488 nm excitation and 530 nm emission. Ten thousand cells were routinely collected, and data were expressed as the median fluorescence intensity in arbitrary units from the average of at least three repeated experiments.
###end p 38
###begin title 39
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 81 82 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
Measurement of calcium levels in the cytoplasm ([Ca2+]c) and mitochondria ([Ca2+]m) of trabecular meshwork cells
###end title 39
###begin p 40
###xml 14 16 14 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 17 18 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 29 30 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 107 108 107 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 135 136 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r54">54</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r56">56</xref>
Changes in [Ca2+]c and [Ca2+]m were measured with the fluorescent probe fluo-3/AM (dissociation constant [Kd] ~400 nM) and Rhod-2/AM (Kd ~570 nM), respectively, as described previously [46,54-56]. Fluorescence intensity of labeled cells was measured using flow cytometry.
###end p 40
###begin p 41
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
The cells were cultured in six-well plates at a density of 1x105 cells per well. After being transfected with pIRES plasmid (Mock), pIRES-WT myocilin, and pIRES-Pro370Leu mutant myocilin for 24 h, TM cells were loaded with either 1 muM fluo-3/AM for 30 min or 1 muM rhod-2/AM for 1 h. The cells were then trypsinized, washed twice with cold PBS, re-suspended in 200 mul PBS, and then immediately analyzed by flow cytometry at an excitation wavelength of 488 nm and an emission wavelength of 525 nm for fluo-3/AM and an excitation wavelength of 549 nm and emission wavelength of 581 nm for Rhod-2/AM. The fluorescent intensity of 10,000 labeled cells was routinely collected for each analysis and the data expressed as the median fluorescence intensity in arbitrary units from the average of at least three repeated experiments.
###end p 41
###begin title 42
Measurement of cellular ATP
###end title 42
###begin p 43
###xml 790 795 <span type="species:ncbi:9606">human</span>
ATP levels were determined using a luciferin/luciferase-based ATP assay. Briefly, cells grown in 24-well plates were transfected with pIRES plasmid (Mock), pIRES-WT myocilin, and pIRES-Pro370Leu mutant myocilin for 24 h. After removal of the treatments, the cell membrane was permeabilized by 100 mul of somatic cell ATP-releasing reagent (FL-SAR; Sigma-Aldrich Co., St Louis, MO) and was allowed to react with 100 mul of ATP Assay Mix Reagent (FLAA; Sigma-Aldrich Co.) containing luciferin and luciferase. After the 10 min incubation at room temperature, luminescence was measured with a 0.5 s integration time using a luminometer (Orion II Luminometer; Berthold Detection Systems, Oak Ridge, TN). The cellular ATP level was expressed as the percentage of luminescence intensity of normal human TM cells.
###end p 43
###begin title 44
Measurement of mitochondrial membrane potential
###end title 44
###begin p 45
###xml 640 641 633 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
JC-1 was used to demonstrate the changes in the mitochondrial membrane potential (DeltaPsim) in TM cells. JC-1 is a lipophilic and cationic dye, which permeates plasma and mitochondrial membranes. The dye fluoresces red when aggregates in healthy mitochondria with high membrane potential, whereas it appears in monomeric form and fluoresces green in mitochondria with diminished membrane potential. JC-1 was freshly diluted in serum-free DMEM to a final concentration of 1 mug/ml and was added to suspending transfected (pIRES, pIRES-WT myocilin, and pIRES-Pro370Leu mutant myocilin for 24 h) and non-transfected cells at a density of 2x106 cells/ml. After incubation for 20 min at 37 degreesC in the dark, all samples were rinsed twice in PBS and analyzed immediately by flow cytometry at 488 nm excitation. Data were collected at 530 nm emission for green fluorescence of the JC-1 monomer on the filter 1 (FL1 detector) and at 590 nm for red fluorescence of JC-1 aggregates on the filter 2 (FL2 detector). Results were presented in relative aggregate to monomer (red:green) fluorescence intensity ratio. Cell numbers in quadrant 4 (Q4; green fluorescent only) were also recorded.
###end p 45
###begin title 46
Statistical analysis
###end title 46
###begin p 47
For quantitative analyses, we conducted triplicate experiments on all five TM samples, and data from 15 trials were averaged. For qualitative analysis, all images were generated from the TM cell of one donor to represent similar changes observed in four other donors' TM cells. Numerical results were analyzed using one-way ANOVA and expressed in mean+/-standard error (SE). Differences were considered statistically significant at p<0.05.
###end p 47
###begin title 48
Results
###end title 48
###begin title 49
Morphological changes of trabecular meshwork cells overexpressing Pro370Leu mutant myocilin
###end title 49
###begin p 50
###xml 162 170 162 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
In phase-contrast micrographs, TM cells that were transfected with Pro370Leu mutant myocilin for 24 h looked unhealthy and exhibited cell shrinkage and shedding (Figure 1). Fewer cells were seen in these cultures in part due to cell death and cell detachment. TM cells with WT myocilin transfection maintained a relatively healthy appearance.
###end p 50
###begin p 51
Morphology change of TM cells after Pro370Leu mutant myocilin transfection. Phase-contrast light micrographs show healthy looking TM cells in non-transfected (Control), pIRES transfected (Mock), or pIRES-WT myocilin transfected (WT) cultures. However, TM cells demonstrate an unhealthy, degenerative appearance after transfection with pIRES-Pro370Leu mutant myocilin (P370L) for 24 h. Fewer cells are seen in these cultures in part due to cell death and cell detachment. Scale bar=30 mum.
###end p 51
###begin title 52
Increased expression of myocilin after transfection
###end title 52
###begin p 53
###xml 320 328 320 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
To determine the transfection efficiency, we transfected the TM cells with pIRES-EGFP plasmid and EGFP-positive cells were quantified using flow cytometry. The TM cells from all five donors showed similar responses to P370L myocilin transfection that EGFP-positive cells comprised 38%-46% of total cells in the culture (Figure 2).
###end p 53
###begin p 54
The efficiency of myocilin transfection. The efficiency of transfection was estimated in TM cells transfected with pIRES-EGFP (Mock), pIRES-WT myocilin (WT), or pIRES-Pro370Leu mutant myocilin (P370L) by counting the percentage of EGFP-positive cells using flow cytometry analysis. The non-transfected TM cells are used as the control. The transfection efficiency was about 38%-46%.
###end p 54
###begin p 55
###xml 215 223 215 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
We then transfected the TM cells with vector carrying WT or Pro370Leu mutant myocilin. After transfection for 48 h, the expression of WT or Pro370Leu was increased as determined by RT-PCR and western blot analysis (Figure 3).
###end p 55
###begin p 56
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
Increased expression of myocilin after transfection. RT- PCR and western blot show that transfection of WT or Pro370Leu (P370L) mutant myocilin increase both myocilin mRNA and protein levels in TM cells after 48 h. GAPDH was used as the internal loading control in RT-PCR while beta-actin and cytochrome C oxidase (COX IV) were used as internal loading controls in western blot analysis for total cell lysate and mitochondrial lysate, respectively. Confocal images show myocilin co-localized with mitochondria. After transfection for 8 h, non-fixed TM cells were immunolabeled with MitoTracker Red, a mitochondria specific dye. Confocal microscopic analyses show that both pIRES-EGFP-WT myocilin (WT) and pIRES-EGFP-Pro370Leu mutant myocilin (P370L) transfected cells have overlapping EGFP staining (green fluorescence) and mitochondria staining (red fluorescence). However, the green fluorescence from pIRES-EGFP (Mock) is diffusive within the cells with no overlapping with mitochondrial staining. Our result indicates co-localization of myocilin and mitochondria in TM cells. Scale bar=30 mum.
###end p 56
###begin title 57
Myocilin co-localizes with mitochondria
###end title 57
###begin p 58
###xml 23 31 23 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
The confocal images in Figure 3 show the mitochondrial staining with MitoTracker Red, a mitochondria specific dye, after transfection with plasmids for 48 h. From the confocal micrographs, both EGFP-WT and EGFP-Pro370Leu mutant myocilin transfected cells had demonstrated overlapping EGFP signals (green fluorescence) and mitochondrial staining (red fluorescence). In cells transfected with pIRES-EGFP (Mock), however, EGFP was expressed everywhere inside the cells, and no overlay with mitochondria was observed. This data indicated that myocilin co-localizatized with mitochondria in TM cells.
###end p 58
###begin title 59
###xml 116 118 116 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 143 145 143 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 146 147 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
Pro370Leu mutant myocilin induces reactive oxygen species generation, increases calcium levels in the cytoplasm ([Ca2+]c) and mitochondria ([Ca2+]m)
###end title 59
###begin p 60
###xml 92 94 92 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 95 96 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 105 107 105 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 180 188 180 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 342 344 340 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 345 346 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 373 375 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 376 377 372 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
We next examined whether myocilin affects the function of mitochondria by measuring ROS, [Ca2+]c, and [Ca2+]m levels in TM cells overexpressing WT or Pro370Leu mutant myocilin. In Figure 4, we present evidence determined by flow cytometry that Pro370Leu mutant myocilin significantly increased ROS generation (2.05+/-0.94 fold) as well as [Ca2+]c (3.17+/-0.64 fold) and [Ca2+]m (1.92+/-0.74 fold) levels in TM cells compared to WT myocilin.
###end p 60
###begin p 61
###xml 159 160 159 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 205 206 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 371 372 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 572 573 570 571 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 574 575 572 573 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 584 586 582 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 587 588 585 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 596 598 594 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 599 600 597 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 671 673 669 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 777 779 773 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 780 781 776 777 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 821 823 815 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 824 825 818 819 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
Pro370Leu mutant myocilin induces ROS generation and increases calcium levels in the cytoplasm and mitochondria in TM cells as estimated using flow cytometry. A: The oxidation sensitive fluorescence dye, H2-DCF-DA, was used to measure the ROS levels in TM cells. TM cells transfected with Pro370Leu (P370L) mutant myocilin transfection show 2.05 fold (+/-0.94) stronger H2-DCF-DA fluorescent intensity than those transfected with WT myocilin (WT), indicating an increase in ROS generation after Pro370Leu mutant myocilin transfection compared to WT myocilin transfection. B,C: The [Ca2+]c and [Ca2+]m indicators, fluo-3/AM and Rhod-2, were used to illustrated the free Ca2+ levels in the cytoplasm and mitochondria, respectively. There was a 3.17 fold (+/-0.64) increase in [Ca2+]c and 1.92 fold (+/-0.74) increase in [Ca2+]m after Pro370Leu mutant myocilin (P370L) transfection compared to WT myocilin transfection (WT). Data are expressed as fold changes in fluorescent levels of transfected TM cells to non-transfected TM cells (Control). Results are expressed as the mean+/-SE of three repeated experiments done in triplicate. An asterisk indicates a significant difference from non-transfected cells at p<0.05.
###end p 61
###begin title 62
Pro370Leu mutant myocilin causes greater endogenous ATP and mitochondrial membrane potential reduction compared to wild type myocilin
###end title 62
###begin p 63
###xml 122 130 116 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
###xml 449 457 437 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f6">Figure 6</xref>
ATP depletion and mitochondrial depolarization (decrease in DeltaPsim) are the major events in mitochondrial dysfunction. Figure 5 shows that there was a decrease in endogenous ATP levels in TM cells after Pro370Leu mutant myocilin transfection compared to those with WT myocilin transfection (p<0.05). In addition, TM cells after Pro370Leu mutant myocilin transfection had a lower DeltaPsim compared to those with WT myocilin transfection (p<0.05; Figure 6).
###end p 63
###begin p 64
Pro370Leu mutant myocilin decreases ATP levels in TM cells. Luciferin/luciferase-based ATP assay indicates that the ATP level in TM with Pro370Leu mutant myocilin (P370L) transfection is 57.7% lower compared to WT myocilin transfection (WT). The ATP levels in non-transfected TM cells (Control) are arbitrarily defined as 100%. The results are expressed as a mean percentage of the ATP levels to the control, error bars represent SE of three repeated experiments done in triplicate. An asterisk indicates a significant difference from non-transfected cells at p<0.05.
###end p 64
###begin p 65
###xml 573 574 555 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 808 809 780 781 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Pro370Leu mutant myocilin further decreases mitochondrial membrane potential in TM cells. DeltaPsim was examined using flow cytometry with the fluorescence indicator, JC-1. The dye fluoresces red when aggregates in healthy mitochondria with high membrane potential, whereas it appears in monomeric form and fluoresces green in mitochondria with diminished membrane potential. The cells number in the Q4 area (green fluorescence) indicates the number of cells with low DeltaPsim. The histogram shows the relative decrease of DeltaPsim to the non-transfected cell (Control). A: The DeltaPsim is 3.03 fold (+/-0.90) lower in TM cells transfected with Pro370Leu mutant myocilin (P370L) compared to TM cells transfected with WT myocilin (WT) while there is a 2.44 fold (+/-0.87) reduction in WT compared to Mock. B: Pro370Leu mutant myocilin transfected TM cells have a significantly lower red to green ratio, and more cells show green fluorescence (cells in Q4 area), indicating Pro370leu mutant myocilin causes a greater mitochondria membrane depolarization. Results are expressed as the mean fold decrease in relative aggregate, a monomer (red:green) ratio of transfected TM to non-transfected TM cells. The error bars represent SE of three repeated experiments done in triplicate. An asterisk indicates a significant difference from non-transfected cells at p<0.05.
###end p 65
###begin title 66
Discussion
###end title 66
###begin p 67
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 428 436 <span type="species:ncbi:9606">patients</span>
###xml 528 533 <span type="species:ncbi:9606">human</span>
Recently, we reported a Pro370Leu mutation of the myocilin gene in a large Chinese autosomal dominant JOAG family (GZ.1) encompassing 56 family members with 19 of them exhibiting JOAG. All these JOAG-affected family members present similar clinical symptoms of high IOP, typical glaucomatous cupping of the optic disc, and a thinner nerve fiber layer and are unresponsive to standard pharmacological treatments [25]. From these patients, we were the first to report that Pro370Leu mutant myocilin enhances ER stress response in human TM cells [45], but how Pro370Leu mutant myocilin affects mitochondrial function is still unclear. Another study has indicated a mutation of this gene causes apoptosis in TM cells [24]. Here, we illustrate the interaction of Pro370Leu myocilin with mitochondria and proposed a possible mechanism that may lead to TM cell damage.
###end p 67
###begin p 68
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 639 644 <span type="species:ncbi:10090">mouse</span>
In this study, we provide evidence of an association between myocilin and mitochondria and found that TM cells expressing Pro370Leu mutant myocilin exhibit mitochondrial dysfunction that is not seen in cells expressing WT myocilin. Sakai et al. showed that the myocilin enters the mitochondria and interacts with the mitochondrial membranes [42]. His findings corroborates results from immunogold labeling, fluorescence labeling, and subcellular fractionation experiments that myocilin is associated with mitochondria in TM cells [39-42]. However, myocilin localization in the mitochondria is not observed in corneal fibroblasts or in the mouse liver. The regulatory mechanisms of such cell-specific localization of myocilin require further investigation, but this phenomenon makes TM cells more sensitive to any undesirable effects of myocilin mutations on the mitochondria.
###end p 68
###begin p 69
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r57">57</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r58">58</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r59">59</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r62">62</xref>
###xml 909 911 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 350 355 <span type="species:ncbi:9606">human</span>
###xml 721 729 <span type="species:ncbi:9606">patients</span>
The fact that both WT and Pro370Leu mutant myocilin sit on the mitochondria raises the question whether these two proteins have different effects to the function of mitochondria. Because growing evidence has shown the relationship between oxidative stresses and exacerbated glaucomatous conditions [17,18,57,58], we compared ROS levels in the normal human TM cells and those cells after WT myocilin or Pro370Leu mutant myocilin transfection. We found that the endogenous ROS level is higher in the TM cells following Pro370Leu mutant myocilin transfection compared to those with WT myocilin transfection, indicating that increased oxidative stress is associated with the pathogenesis of Pro370Leu mutant myocilin in POAG patients. There is a general consensus that cumulative oxidative damage is responsible for general aging [59-62]. Although many individuals with POAG were young adults in the GZ.1 family [25], the higher ROS levels in the TM cells with Pro370Leu mutant myocilin gene could possibly accelerate the aging process in this region, which may in part contribute to the progression of POAG.
###end p 69
###begin p 70
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 286 288 286 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Myocilin increases both [Ca2+]c and [Ca2+]m, possibly through the disregulation of calcium channels. Calcium-dependent contractibility of TM cells control outflow of the aqueous humor, which maintains IOP. Failure in closing the L-type calcium channel leads to an excessive influx of Ca2+, causing membrane depolarization, TM contraction, reduced outflow, and IOP elevation. Though a direct interaction between Pro370Leu mutant myocilin and the L-type calcium channel is not conclusive from our data, it is a possible explanation to our observation.
###end p 70
###begin p 71
###xml 138 140 138 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 194 196 194 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r63">63</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r64">64</xref>
###xml 239 241 239 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 267 269 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r65">65</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r66">66</xref>
On top of its ATP generation ability, the mitochondria also plays a part in modulating the amplitude and spatiotemporal organization of Ca2+ signals through rapidly accumulating and releasing Ca2+ [63,64]. However, excessive cytoplasmic Ca2+ leads to mitochondrial Ca2+ overload, which triggers ROS overproduction, mitochondrial membrane depolarization, and ATP production inhibition, all hallmark events of mitochondrial dysfunction and eventual apoptosis [65,66].
###end p 71
###begin p 72
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 208 209 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 340 341 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r67">67</xref>
###xml 517 518 517 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r68">68</xref>
###xml 798 799 794 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 974 976 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 977 979 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r69">69</xref>
###xml 980 982 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r71">71</xref>
Studies showed that myocilin is imported into the mitochondria and may target the inner and outer membranes and inter-membrane space [42]. However, the structure of myocilin does not seem to have a typical NH2-terminal mitochondrial-targeting presequence. Myocilin is predicted to contain a potential mitochondrial transit peptide at its NH2-terminus (amino acid residues 1-47) using the PCGene program (IntelliGenetics Inc., Mountain View, CA) base on the charge transition and R(2) weak rule [67]. Also, both the NH2- and COOH-termini of myocilin contain a lysine- and arginine-rich mitochondrial tethering domain (amino acid residues 33-46 and 460-504) [68]. Like the predictions for other mitochondrial outer membrane proteins, some data showed the alpha-helical transmembrane segment of the NH2-terminal is the main contributor for myocilin to incorporate into mitochondrial membranes, while the beta-sheet segment at the COOH-terminus play a comparatively minor role [42,69-71]. However, the exact targeting sequence for mitochondrial translocation of myocilin is still unclear.
###end p 72
###begin p 73
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r70">70</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r72">72</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r75">75</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r76">76</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r78">78</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r79">79</xref>
###xml 704 706 704 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Myocilin appears to be imported into the mitochondria with the aid of a high molecular weight translocator complex in the outer and inner mitochondrial membranes [42], which has been demonstrated with other mitochondrial proteins [70,72-75]. Mutation in myocilin alters the protein structure and conformation [76-78]. Since Pro370Leu is located within the highly conserved Olfactomedin (OLF)-domain at the COOH-terminus of myocilin [79], it is possible that the mutation changes the protein structure and conformation, which negatively impacts the mitochondrial inner and outer membrane functions. The alteration in mitochondria may subsequently lead to differential effects on ROS and ATP generation, Ca2+ levels in cytoplasm and mitochondria, and DeltaPsim in TM cells.
###end p 73
###begin p 74
###xml 184 186 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 708 710 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 711 713 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 475 480 <span type="species:ncbi:9606">human</span>
In conclusion, we present strong evidence of the association of myocilin with mitochondria. Increased generation of ROS, decreased ATP production, decreased DeltaPsim, and increased Ca2+ levels in both the cytoplasm and mitochondria in TM cells with Pro370Leu mutant myocilin gene transfection indicate that Pro370Leu mutant myocilin can affect mitochondria functions. The mutation increases vulnerability in the mitochondria to various cellular injuries and disables normal human TM cells functions, which may eventually contribute to the failure of the TM to control IOP. New insights on the protective effects of antioxidants and mitochondria permeability transition inhibitors to the health of TM cells [18,46] suggest that there are POAG treatment possibilities that are worthy of further investigation.
###end p 74
###begin title 75
Acknowledgments
###end title 75
###begin p 76
This work was supported by grants from the National Basic Research Program of China (No. 2007CB512200) and the National Natural Science Foundation of China (No.30672275, No.30400486). The first author received support from the China Scholarship Council.
###end p 76
###begin title 77
References
###end title 77
###begin article-title 78
###xml 10 16 <span type="species:ncbi:9606">people</span>
Number of people with glaucoma worldwide.
###end article-title 78
###begin article-title 79
###xml 31 37 <span type="species:ncbi:9606">people</span>
Common eye diseases of elderly people: identifying and treating causes of vision loss.
###end article-title 79
###begin article-title 80
Global data on blindness.
###end article-title 80
###begin article-title 81
The global impact of glaucoma.
###end article-title 81
###begin article-title 82
Global data on visual impairment in the year 2002.
###end article-title 82
###begin article-title 83
The resistance of the trabecular meshwork to aqueous humor outflow.
###end article-title 83
###begin article-title 84
###xml 24 29 <span type="species:ncbi:9606">human</span>
Genetic modification of human trabecular meshwork with lentiviral vectors.
###end article-title 84
###begin article-title 85
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Analysis of myocilin mutations in 1703 glaucoma patients from five different populations.
###end article-title 85
###begin article-title 86
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma.
###end article-title 86
###begin article-title 87
Vascular dysregulation: a principal risk factor for glaucoma damage?
###end article-title 87
###begin article-title 88
Vascular aspects in the pathophysiology of glaucomatous optic neuropathy.
###end article-title 88
###begin article-title 89
Open-angle glaucoma.
###end article-title 89
###begin article-title 90
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.
###end article-title 90
###begin article-title 91
The Advanced Glaucoma Intervention Study (AGIS): The relationship between control of intraocular pressure and visual field deterioration.
###end article-title 91
###begin article-title 92
Collaborative Initial Glaucoma Treatment Study: a summary of results to date.
###end article-title 92
###begin article-title 93
###xml 24 29 <span type="species:ncbi:9606">human</span>
Oxidative DNA damage in human trabecular meshwork and its correlation with intraocular pressure and visual field in primary open angle glaucoma.
###end article-title 93
###begin article-title 94
###xml 105 113 <span type="species:ncbi:9606">Patients</span>
Mitochondrial Complex I Defect Induces ROS Release and Degeneration in Trabecular Meshwork Cells of POAG Patients: Protection by Antioxidants.
###end article-title 94
###begin article-title 95
Identification of a gene that causes primary open angle glaucoma
###end article-title 95
###begin article-title 96
Genetic dissection of myocilin glaucoma.
###end article-title 96
###begin article-title 97
Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma.
###end article-title 97
###begin article-title 98
GLC1A mutations point to regions of potential functional importance on the TIGR/MYOC protein.
###end article-title 98
###begin article-title 99
###xml 17 25 <span type="species:ncbi:9606">patients</span>
Gene mutation in patients with primary open-angle glaucoma in a pedigree in China.
###end article-title 99
###begin article-title 100
A preliminary study on gene mutation and its function in a large family (GZ.1 pedigree) with open-angle glaucoma.
###end article-title 100
###begin article-title 101
Pro370Leu MYOC gene mutation in a large Chinese family with juvenile-onset open angle glaucoma: correlation between genotype and phenotype.
###end article-title 101
###begin article-title 102
###xml 81 86 <span type="species:ncbi:9606">human</span>
In and out of the ER: protein folding, quality control, degradation, and related human disease.
###end article-title 102
###begin article-title 103
The road taken: past and future foundations of membrane traffic.
###end article-title 103
###begin article-title 104
The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes.
###end article-title 104
###begin article-title 105
Constitutive protein secretion from the trans-Golgi network to the plasma membrane.
###end article-title 105
###begin article-title 106
###xml 95 100 <span type="species:ncbi:9606">human</span>
Distribution of myocilin and extracellular matrix components in the juxtacanalicular tissue of human eyes.
###end article-title 106
###begin article-title 107
###xml 94 99 <span type="species:ncbi:9606">human</span>
Distribution of myocilin and extracellular matrix components in the corneoscleral meshwork of human eyes.
###end article-title 107
###begin article-title 108
###xml 55 60 <span type="species:ncbi:9606">human</span>
Expression of the glaucoma gene myocilin (MYOC) in the human optic nerve head.
###end article-title 108
###begin article-title 109
###xml 54 59 <span type="species:ncbi:9606">human</span>
Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues.
###end article-title 109
###begin article-title 110
Localization of the stress proteins alpha B-crystalline and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork.
###end article-title 110
###begin article-title 111
Identification of the region in the N-terminal domain responsible for the cytoplasmic localization of MYOC/TIGR and its association with microtubules.
###end article-title 111
###begin article-title 112
Localization of myocilin to the Golgi apparatus in Schlemm's canal cells.
###end article-title 112
###begin article-title 113
###xml 43 48 <span type="species:ncbi:9606">human</span>
Regulation of TIGR/MYOC gene expression in human trabecular meshwork cells.
###end article-title 113
###begin article-title 114
Isolation, culture, and characterization of endothelial cells from Schlemm's canal.
###end article-title 114
###begin article-title 115
###xml 45 50 <span type="species:ncbi:9606">human</span>
Ultra-structural localization of myocilin in human trabecular meshwork cells and tissues.
###end article-title 115
###begin article-title 116
###xml 44 49 <span type="species:ncbi:9606">human</span>
Myocilin is associated with mitochondria in human trabecular meshwork cells.
###end article-title 116
###begin article-title 117
###xml 54 59 <span type="species:ncbi:9606">human</span>
Distribution of myocilin, a glaucoma gene product, in human corneal Ô¨Åbroblasts.
###end article-title 117
###begin article-title 118
###xml 70 75 <span type="species:ncbi:9606">human</span>
Mitochondrial association of myocilin, product of a glaucoma gene, in human trabecular meshwork cells.
###end article-title 118
###begin article-title 119
Myocilin and glaucoma: facts and ideas.
###end article-title 119
###begin article-title 120
###xml 43 48 <span type="species:ncbi:9606">human</span>
mRNA in situ hybridization of TIGR/MYOC in human trabecular meshwork.
###end article-title 120
###begin article-title 121
###xml 115 120 <span type="species:ncbi:9606">human</span>
Pro370Leu mutant myocilin disturbs the endoplasm reticulum stress response and mitochondrial membrane potential in human trabecular meshwork cells.
###end article-title 121
###begin article-title 122
Mitochondrial Defects and Dysfunction in Calcium Regulation in Glaucomatous Trabecular Meshwork Cells.
###end article-title 122
###begin article-title 123
###xml 34 39 <span type="species:ncbi:9606">human</span>
Genome-wide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open angle glaucoma tissue.
###end article-title 123
###begin article-title 124
Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor beta.
###end article-title 124
###begin article-title 125
###xml 79 84 <span type="species:ncbi:9606">human</span>
Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures.
###end article-title 125
###begin article-title 126
###xml 44 49 <span type="species:ncbi:9606">Human</span>
Isolation, Culture, and Characterization of Human Fetal Trabecular Meshwork Cells.
###end article-title 126
###begin article-title 127
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human trabecular meshwork cells in culture: morphology and extracellular matrix components.
###end article-title 127
###begin article-title 128
###xml 21 26 <span type="species:ncbi:9606">human</span>
Proteins secreted by human trabecular cells. Glucocorticoid and other effects.
###end article-title 128
###begin article-title 129
Measuring mitochondrial reactive oxygen species.
###end article-title 129
###begin article-title 130
Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells.
###end article-title 130
###begin article-title 131
###xml 49 69 <span type="species:ncbi:28545">Strychnos nux-vomica</span>
###xml 73 78 <span type="species:ncbi:9606">human</span>
The apoptotic effect of brucine from the seed of Strychnos nux-vomica on human hepatoma cells is mediated via Bcl-2 and Ca2+ involved mitochondrial pathway.
###end article-title 131
###begin article-title 132
[Ca2+]i signaling between mitochondria and endoplasmic reticulum in neurons is regulated by microtubules. From mitochondrial permeability transition pore to Ca2+-induced Ca2+ release.
###end article-title 132
###begin article-title 133
The role of oxidative stress in glaucoma.
###end article-title 133
###begin article-title 134
Glaucomatous outflow pathway and oxidative stress.
###end article-title 134
###begin article-title 135
Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens.
###end article-title 135
###begin article-title 136
Contributions of mitochondria to animal physiology: from homeostatic sensor to calcium signaling and cell death.
###end article-title 136
###begin article-title 137
Mitochondrial disease: powerhouse of disease.
###end article-title 137
###begin article-title 138
Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging.
###end article-title 138
###begin article-title 139
Apoptosis driven by IP3-linked mitochondrial calcium signals.
###end article-title 139
###begin article-title 140
###xml 49 69 <span type="species:ncbi:28545">Strychnos nux-vomica</span>
The apoptotic effect of brucine from the seed of Strychnos nux-vomica onhuman hepatoma cells is mediated via Bcl-2 and Ca2+ involved mitochondrial pathway.
###end article-title 140
###begin article-title 141
###xml 57 60 <span type="species:ncbi:10116">rat</span>
Mitochondrial modulation of Ca2+-induced Ca2+-release in rat sensory neurons.
###end article-title 141
###begin article-title 142
Combined modulation of the mitochondrial ATP-dependent potassium channel and the permeability transition pore causes prolongation of the biphasic calcium dynamics.
###end article-title 142
###begin article-title 143
Cleavage site motifs in mitochondrial targeting peptides.
###end article-title 143
###begin article-title 144
FAST is a BCL-XL-associated mitochondrial protein.
###end article-title 144
###begin article-title 145
Regulation of mitochondrial morphology and inheritance by Mdm10p, a protein of the mitochondrial outer membrane.
###end article-title 145
###begin article-title 146
The protein importmachinery of mitochondria.
###end article-title 146
###begin article-title 147
###xml 59 64 <span type="species:ncbi:4932">yeast</span>
Mmm2p, a mitochondrial outer membrane protein required for yeast mitochondrial shape and maintenance of mtDNA nucleoids.
###end article-title 147
###begin article-title 148
Mechanisms of protein import into mitochondria.
###end article-title 148
###begin article-title 149
The pathophysiology of mitochondrial cell death.
###end article-title 149
###begin article-title 150
Mitochondrial import and the twin-pore translocase.
###end article-title 150
###begin article-title 151
Protein import into mitochondria.
###end article-title 151
###begin article-title 152
In vitro and in vivo study on the secretion of the Gly367Arg mutant myocilin protein.
###end article-title 152
###begin article-title 153
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Evaluation and understanding of myocilin mutations in Indian primary open angle glaucoma patients.
###end article-title 153
###begin article-title 154
A review of genetic and structural understanding of the role of myocilin in primary open angle glaucoma.
###end article-title 154
###begin article-title 155
Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells.
###end article-title 155

